Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 1Inflammatory Bowel Diseases 1Crohn Disease 1Colitis, Ulcerative 1Brain Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Indigo Carmine × Clear all
NCT01505842 2019-03-06

Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease

Karolinska University Hospital

Phase NA Unknown
304 enrolled

Colitis, Ulcerative, Crohn Disease, Neoplasms, Inflammatory Bowel Diseases

NCT01767415 2018-12-11

Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection

Weill Medical College of Cornell University

Phase 1/2 Completed
10 enrolled 11 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡